SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,540.00    90.00 (2.02%)
Bid:
4,500.00
Ask:
4,580.00
Spread: 80.00 (1.778%)
Market Cap: £302.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
4th Dec 20197:00 amRNSAcquisition of Moorfield Nanotechnology Limited
21st Nov 20197:00 amRNSSpecial dividend
15th Nov 20197:00 amRNSBlocklisting Return
7th Nov 20193:19 pmRNSDirector/PDMR Shareholding
7th Nov 20192:38 pmRNSDirector/PDMR Shareholding
1st Nov 201910:49 amRNSTotal Voting Rights
9th Oct 201910:20 amRNSDirector/PDMR Shareholding
23rd Sep 20193:49 pmRNSHolding(s) in Company
23rd Sep 20198:45 amRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results
16th Sep 20191:39 pmRNSHolding(s) in Company
9th Sep 201911:26 amRNSDirector/PDMR Shareholding
27th Aug 20191:18 pmRNSHolding(s) in Company
7th Aug 201910:39 amRNSDirector/PDMR Shareholding
2nd Aug 20194:01 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSAppointment of Liberum as Joint Broker
22nd Jul 20197:00 amRNSTrading Update and Notice of Interim Results
17th Jul 201911:43 amRNSHolding(s) in Company
17th Jul 201911:41 amRNSHolding(s) in Company
12th Jul 20199:23 amRNSDirector/PDMR Shareholding
9th Jul 20195:17 pmRNSDirector/PDMR Shareholding
28th Jun 20194:27 pmRNSHolding(s) in Company
7th Jun 20199:14 amRNSDirector/PDMR Shareholding
5th Jun 201912:05 pmRNSBlock listing Interim Review
3rd Jun 201911:57 amRNSTotal Voting Rights
22nd May 20191:39 pmRNSResult of AGM
16th May 20195:37 pmRNSDirector/PDMR Shareholding
9th May 20194:14 pmRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSTotal Voting Rights
29th Apr 20194:21 pmRNSNotice of AGM
9th Apr 20197:00 amRNSHolding(s) in Company
8th Apr 20195:53 pmRNSDirector/PDMR Shareholding
5th Apr 20199:30 amRNSDirector/PDMR Shareholding
1st Apr 20195:59 pmRNSHolding(s) in Company
1st Apr 201912:35 pmRNSTotal Voting Rights
22nd Mar 201911:54 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
7th Mar 20192:22 pmRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
7th Feb 20192:34 pmRNSDirector/PDMR Shareholding
5th Feb 20197:00 amRNSHolding(s) in Company
17th Jan 20197:00 amRNSTrading Statement and Notice of Final Results
9th Jan 20197:00 amRNSDirector/PDMR Shareholding
21st Dec 20183:21 pmRNSDirector/PDMR Shareholding
7th Dec 20187:00 amRNSDirector/PDMR Shareholding
4th Dec 201812:41 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
15th Nov 20187:00 amRNSBlock listing Interim Review
13th Nov 20185:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.